Boston Scientific Corp <BSX.N>: RBC cuts target price to $85 from $100
BSX•Related News
Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlook
MLSS•
Digi Power X Q2 FY26 net loss widens to $14.4 million; revenue rises to $6.6 million
DGXX•
Hertz Global Holdings <HTZ.O>: Deutsche Bank raises target price to $2.8 from $2.65
HTZ•
Eton Pharmaceuticals rises on Q2 profit beat
ETON•
Heartflow, Inc. <HTFL.O>: Stifel raises target price to $45 from $40
HTFL•